A Study of IBI377 in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease
Status:
Terminated
Trial end date:
2020-10-10
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate itacitinib in combination with corticosteroids as
first-line treatment of participants with Grade II to IV acute graft-versus-host disease
(aGVHD).